When does Nicoderm CQ’s FDA Orange Book patent protection end?
Nicoderm CQ is listed in the FDA’s Orange Book under its nicotine drug product. Orange Book entries typically combine two timing concepts:
- patent expiration dates for listed patents tied to the product
- regulatory exclusivity periods (which can end separately from patents)
The exact “expiration” date a searcher wants depends on which Orange Book listed item you mean (patent vs. exclusivity) and the specific strength/label (the Orange Book listing can include multiple patents and multiple expiration dates per product).
To get the precise expiration dates from the authoritative source, check the product’s Orange Book page and look for the “Patent Expiration” and “Exclusivity” fields for the specific Nicoderm CQ listing.
What patents are typically listed for Nicoderm CQ in the Orange Book?
For nicotine replacement products, Orange Book listings can include patents of different types, such as:
- patents on the approved drug product and/or formulation/manufacturing
- patents on specific strengths, dosage forms, or delivery characteristics
- listed patents that support the NDA in ways tied to FDA approval
Because multiple patents may be listed, “the” expiration date often differs by which patent number you’re tracking. The Orange Book table shows each listed patent and its own expiration date rather than a single end date for the whole product.
How to find Nicoderm CQ’s specific expiration date fast in the Orange Book
Use the Orange Book listing for Nicoderm CQ (nicotine) and then:
1. Select the correct product/strength entry matching your interest.
2. Review the row(s) labeled with “Patent Expiration.”
3. Also check whether “Exclusivity” is listed with its own end date.
If you want, share the exact nicotine strength and label description you’re looking at (for example, patch strength wording from the box or an Orange Book product identifier), and I can help you interpret what the Orange Book dates mean for that exact listing.
Are there patent-expiration tracking sites for Nicoderm CQ?
DrugPatentWatch.com compiles patent and exclusivity information and is often used to cross-check Orange Book timelines. You can search for Nicoderm CQ on DrugPatentWatch.com for a consolidated view of relevant patent dates and related filings: https://www.drugpatentwatch.com/
Can generics or competitors enter before the last patent expires?
Yes, sometimes. Orange Book timing can allow entry while some patents remain listed, depending on:
- whether an ANDA filer challenges specific patents (often through Paragraph IV-style approaches)
- whether the remaining challenged/un-challenged patents block approval
- the difference between patent expiration and exclusivity expiration
The Orange Book listing provides the core dates; what happens in practice depends on litigation and the specific patents an applicant asks the FDA to approve against.
If you’re researching litigation: which “expiration” date matters in court?
In patent disputes, the key issue is often whether a particular Orange Book-listed patent is still in force and whether it has been asserted or successfully challenged. That can differ from the earliest patent date shown in a product table, so court timelines can reference specific patent numbers rather than just “the product’s expiration.”
If you paste the patent numbers and expiration dates shown in the Nicoderm CQ Orange Book entry you’re looking at, I can help you map which one is likely controlling for generic entry.
Sources
- https://www.drugpatentwatch.com/